Latest Breaking News On - Eton pharmaceuticals - Page 10 : comparemela.com

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone

Expect Q1 2024 product launch Nitisinone market estimated to be more than $50 million annually Eton will offer Eton Cares support program to all patients DEER PARK, Ill., Oct. 04,.

United statesLisam wilsonSean brynjelsenEton pharmaceuticalsSite communications incOakrum pharmaEton pharmaceuticals incExchange commissionDrug administrationCompany nasdaqEton caresNitisinone capsulesCarglumic acidBetaine anhydrousOrphan drug designationPrivate securities litigation reform act

Eton Pharmaceuticals (ETON) Acquires FDA-Approved Ultra-Rare Disease Product Nitisinone

Eton Pharmaceuticals (ETON) Acquires FDA-Approved Ultra-Rare Disease Product Nitisinone
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSean brynjelsenDrug administrationEton pharmaceuticals incEton pharmaceuticalsOakrum pharmaEton pharmaceuticals nasdaqNitisinone capsulesCarglumic acidEton cares

Westside Investment Management Inc Lowers Stock Position in Harrow Health, Inc (NASDAQ:HROW)

Westside Investment Management Inc. reduced its stake in Harrow Health, Inc. (NASDAQ:HROW – Free Report) by 11.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 133,744 shares of the company’s stock after selling 16,865 shares during the quarter. Westside Investment […]

Markl baumZurcher kantonalbank zurich cantonalbankPharmaceuticals incNews ratings for harrow health dailyHarrow healthQuarter for harrow healthHarrow health company profileWestside investment management incHarrow health incExchange commissionSecurities exchange commissionHarrow health stockMendota financial groupInsider activity at harrow healthMarshall waceEton pharmaceuticals inc

Financial Review: Eton Pharmaceuticals (NASDAQ:ETON) versus Creative Edge Nutrition (OTCMKTS:FITX)

Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) and Creative Edge Nutrition (OTCMKTS:FITX – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk. Institutional & Insider Ownership 23.3% of Eton […]

Madison heightsUnited statesDeer parkNews ratings for eton pharmaceuticals dailyEton pharmaceuticalsEnterprises incEton pharmaceuticals incCreative edge nutrition incGet free reportCreative edge nutritionGiven eton pharmaceuticalCreative edgeEdge nutritionCarglumic acidN acetylglutamate synthaseBetaine anhydrous

Eton Pharmaceuticals, Inc (NASDAQ:ETON) Sees Large Decrease in Short Interest

Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Free Report) saw a large drop in short interest in the month of August. As of August 31st, there was short interest totalling 958,600 shares, a drop of 27.4% from the August 15th total of 1,320,000 shares. Based on an average daily trading volume, of 413,400 shares, the short-interest […]

Eton pharmaceuticals incGoldman sachs group incEton pharmaceuticals trading downJpmorgan chase coVirtu financialHedge funds weigh in on eton pharmaceuticalsNews ratings for eton pharmaceuticals dailyEton pharmaceuticalsGet free reportPharmaceuticals trading downStreet corpSachs groupCarglumic acidN acetylglutamate synthaseBetaine anhydrousEton pharmaceuticals daily